CHGN-111

N/A

Report date: 2022/10/21 10:15:04
NME

Base Information

Drug NameCHGN-111
Drug Alias NameCHGN111CHGN-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity protein kinase CLK1 inhibitors
TargetsDual specificity protein kinase CLK1
Therapy Area/IndicationsPhotophobia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChronogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChronogen Inc
Active IndicationsN/A
Inactive IndicationsPhotophobia

Other Information

ATC CodeN/A
Related LinksN/A